Background: Auditory synaptopathy/neuropathy (AS/AN) is a heterogeneous disorder, which may be caused by environmental factors like postnatal hyperbilirubinemia or by genetic factors. The genetic forms are subdivided into syndromic and non-syndromic types, and show different inheritance patterns with a strong preponderance of autosomal-recessive forms. To date, only a single locus for non-syndromic autosomal-dominant AS/AN (AUNA1) has been reported in a single family, in which a non-coding DIAPH3 mutation was subsequently described as causative. Materials and Methods: Here, we report detailed clinical data on a large German AS/AN family with slowly progressive postlingual hearing loss. Affected family members developed their first symptoms in their second decade. Moderate hearing loss in the fourth decade then progressed to profound hearing impairment in older family members. Comprehensive audiological and neurological tests were performed in the affected family members. Genetic testing comprised linkage analyses with polymorphic markers and a genome-wide linkage analysis using the Affymetrix GeneChip® Human Mapping 250K. Results and Conclusion: We identified a large family with autosomal-dominant AS/AN. By means of linkage analyses, the AUNA1 locus was excluded, and putatively linked regions on chromosomal bands 12q24 and 13q34 were identified as likely carrying the second locus for autosomal-dominant AS/AN (AUNA2). AUNA2 is associated with a slowly progressive postlingual hearing loss without any evidence for additional symptoms in other organ systems.

Keywords:
Auditory synaptopathy, Auditory neuropathy, Progressive hearing loss, AUNA, Autosomal-dominant inheritance
1.
Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferre M, Guillet V, Gueguen N, Loiseau D, de Crescenzo M-AP, Verny C, Procaccio V, Lenaers G, Reynier P: OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol 2009;41:1855-1865.
2.
Bae S-H, Baek J-I, Lee JD, Song MH, Kwon T-J, Oh S-K, Jeong JY, Choi JY, Lee K-Y, Kim U-K: Genetic analysis of auditory neuropathy spectrum disorder in the Korean population. Gene 2013;522:65-69.
3.
Berlin CI, Hood LJ, Morlet T, Wilensky D, Li L, Mattingly KR, Taylor-Jeanfreau J, Keats BJB, John PS, Montgomery E, Shallop JK, Russell BA, Frisch SA: Multi-site diagnosis and management of 260 patients with auditory neuropathy/dys-synchrony (auditory neuropathy spectrum disorder). Int J Audiol 2010;49:30-43.
4.
Beutner D, Foerst A, Lang-Roth R, Wedel H von, Walger M: Risk factors for auditory neuropathy/auditory synaptopathy. ORL J Otorhinolaryngol Relat Spec 2007;69:239-244.
5.
Bielecki I, Horbulewicz A, Wolan T: Risk factors associated with hearing loss in infants: an analysis of 5282 referred neonates. Int J Pediatr Otorhinolaryngol 2011;75:925-930.
6.
Bielecki I, Horbulewicz A, Wolan T: Prevalence and risk factors for auditory neuropathy spectrum disorder in a screened newborn population at risk for hearing loss. Int J Pediatr Otorhinolaryngol 2012;76:1668-1670.
7.
Blanton SH, Liang CY, Cai MW, Pandya A, Du LL, Landa B, Mummalanni S, Li KS, Chen ZY, Qin XN, Liu YF, Balkany T, Nance WE, Liu XZ: A novel locus for autosomal dominant non-syndromic deafness (DFNA41) maps to chromosome 12q24-qter. J Med Genet 2002;39:567-570.
8.
Bonsch D, Schmidt C-M, Scheer P, Bohlender J, Neumann C, Am Zehnhoff-Dinnesen A, Deufel T: A new gene locus for an autosomal-dominant non-syndromic hearing impairment (DFNA 33) is situated on chromosome 13q34-qter. HNO 2009;57:371-376.
9.
Chilla R, Gabriel P, Kozielski P, Bänsch D, Kabas M: The Göttingen audiometric speech test for children. I. Speech audiometry of the young and retarded child by a picture-test. HNO 1976;24:342-346.
10.
Collin RWJ, Kalay E, Oostrik J, Çaylan R, Wollnik B, Arslan S, den Hollander AI, Birinci Y, Lichtner P, Strom TM, Toraman B, Hoefsloot LH, Cremers CWRJ, Brunner HG, Cremers FPM, Karaguzel A, Kremer H: Involvement ofDFNB59 mutations in autosomal recessive nonsyndromic hearing impairment. Hum Mutat 2007;28:718-723.
11.
Doyle KJ, Sininger Y, Starr A: Auditory neuropathy in childhood. Laryngoscope 1998;108:1374-1377.
12.
Duman D, Tekin M: Autosomal recessive nonsyndromic deafness genes: a review. Front Biosci (Landmark Ed) 2012;17:2213-2236.
13.
Endo A, Fuchigami T, Hasegawa M, Hashimoto K, Fujita Y, Inamo Y, Mugishima H: Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature. Pediatr Emerg Care 2012;28:153-157.
14.
Foerst A, Beutner D, Lang-Roth R, Huttenbrink K-B, Wedel H von, Walger M: Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss. Int J Pediatr Otorhinolaryngol 2006;70:1415-1422.
15.
Gabriel P, Chilla R, Kiese C, Kabas M, Bänsch D: The Göttingen audiometric speech test for children. II. Speech audiometry of the pre-school child with a monosyllabic picture test. HNO 1976;24:399-402.
16.
Grati FR, Lesperance MM, Toffol S de, Chinetti S, Selicorni A, Emery S, Grimi B, Dulcetti F, Malvestiti B, Taylor J, Milani S, Ruggeri AM, Maggi F, Simoni G: Pure monosomy and pure trisomy of 13q21.2-31.1 consequent to a familial insertional translocation: exclusion of PCDH9 as the responsible gene for autosomal dominant auditory neuropathy (AUNA1). Am J Med Genet 2009;149A:906-913.
17.
Greene CC, McMillan PM, Barker SE, Kurnool P, Lomax MI, Burmeister M, Lesperance MM: DFNA25, a novel locus for dominant nonsyndromic hereditary hearing impairment, maps to 12q21-24. Am J Hum Genet 2001;68:254-260.
18.
Hahlbrock KH: Speech audiometry and new word-tests. Arch Ohren Nasen Kehlkopfheilkd 1953;162:394-431.
19.
Hangen E, Blomgren K, Benit P, Kroemer G, Modjtahedi N: Life with or without AIF. Trends Biochem Sci 2010;35:278-287.
20.
He S, Teagle HFB, Roush P, Grose JH, Buchman CA: Objective hearing threshold estimation in children with auditory neuropathy spectrum disorder. Laryngoscope 2013:123:2859-2861.
21.
Iwasa Y, Nishio S, Yoshimura H, Kanda Y, Kumakawa K, Abe S, Naito Y, Nagai K, Usami S: OTOF mutation screening in Japanese severe to profound recessive hearing loss patients. BMC Med Genet 2013;14:95.
22.
Jian W, Ying-ying F, Shu-juan W, Peng-Fei L, Jin-ling W, Jian-hua Q, Yan J: Variants of OTOF and PJVK genes in Chinese patients with auditory neuropathy spectrum disorder. PLoS One 2011;6:e24000.
23.
Kim TB, Isaacson B, Sivakumaran TA, Starr A, Keats, B J B, Lesperance MM: A gene responsible for autosomal dominant auditory neuropathy (AUNA1) maps to 13q14-21. J Med Genet 2004;41:872-876.
24.
Manchaiah VK, Zhao F, Danesh AA, Duprey R: The genetic basis of auditory neuropathy spectrum disorder (ANSD). Int J Pediatr Otorhinolaryngol 2011;75:151-158.
25.
Marlin S, Feldmann D, Nguyen Y, Rouillon I, Loundon N, Jonard L, Bonnet C, Couderc R, Garabedian EN, Petit C, Denoyelle F: Temperature-sensitive auditory neuropathy associated with an otoferlin mutation: deafening fever! Biochem Biophys Res Commun 2010;394:737-742.
26.
Mazzoli M, van Camp G, Newton V, Giarbini N, Declau F, Parving A; GENDEAF: Recommendations for the description of genetic and audiological data for families with nonsyndromic hereditary hearing impairment. Audiological Med 2003;1:148-150.
27.
McMahon CM, Patuzzi RB, Gibson WPR, Sanli H: Frequency-specific electrocochleography indicates that presynaptic and postsynaptic mechanisms of auditory neuropathy exist. Ear Hear 2008;29:314-325.
28.
Moser T, Predoehl F, Starr A: Review of hair cell synapse defects in sensorineural hearing impairment. Otol Neurotol 2013;34:995-1004.
29.
Moser T, Strenzke N, Meyer A, Lesinski-Schiedat A, Lenarz T, Beutner D, Foerst A, Lang-Roth R, Wedel H von, Walger M, Gross M, Keilmann A, Limberger A, Steffens T, Strutz J: Diagnostik und Therapie der auditorischen Synaptopathie/Neuropathie. HNO 2006;54:833-839.
30.
Namba K, Mutai H, Takiguchi Y, Yagi H, Okuyama T, Oba S, Yamagishi R, Kaneko H, Shintani T, Kaga K, Matsunaga T: Molecular impairment mechanisms of novel OPA1 mutations predicted by molecular modeling in patients with autosomal dominant optic atrophy and auditory neuropathy spectrum disorder. Otol Neurotol 2016;37:394-402.
31.
Narne VK, Vanaja C: Speech identification and cortical potentials in individuals with auditory neuropathy. Behav Brain Funct 2008;4:15.
32.
Nikolopoulos TP: Auditory dyssynchrony or auditory neuropathy: understanding the pathophysiology and exploring methods of treatment. Int J Pediatr Otorhinolaryngol 2014;78:171-173.
33.
Pangršič T, Reisinger E, Moser T: Otoferlin: a multi-C2 domain protein essential for hearing. Trends Neurosci 2012;35:671-680.
34.
Penido RC, Isaac ML: Prevalence of auditory neuropathy spectrum disorder in an auditory health care service. Brazil J Otorhinolaryngol 2013;79:429-433.
35.
Rance G, Beer DE, Cone-Wesson B, Shepherd RK, Dowell RC, King AM, Rickards FW, Clark GM: Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 1999;20:238-252.
36.
Roux I, Safieddine S, Nouvian R, Grati M, Simmler M-C, Bahloul A, Perfettini I, Le Gall M, Rostaing P, Hamard G, Triller A, Avan P, Moser T, Petit C: Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 2006;127:277-289.
37.
Ruel J, Emery S, Nouvian R, Bersot T, Amilhon B, van Rybroek JM, Rebillard G, Lenoir M, Eybalin M, Delprat B, Sivakumaran TA, Giros B, El Mestikawy S, Moser T, Smith RJH, Lesperance MM, Puel J-L: Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet 2008;83:278-292.
38.
Saluja S, Agarwal A, Kler N, Amin S: Auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice. Int J Pediatr Otorhinolaryngol 2010;74:1292-1297.
39.
Santarelli R, Arslan E: Electrocochleography in auditory neuropathy. Hear Res 2002;170:32-47.
40.
Santarelli R, Del Castillo I, Cama E, Scimemi P, Starr A: Audibility, speech perception and processing of temporal cues in ribbon synaptic disorders due to OTOF mutations. Hear Res 2015;330:200-212.
41.
Schoen CJ, Burmeister M, Lesperance MM: Diaphanous homolog 3 (Diap3) overexpression causes progressive hearing loss and inner hair cell defects in a transgenic mouse model of human deafness. PLoS One 2013;8:e56520.
42.
Schoen CJ, Emery SB, Thorne MC, Ammana HR, Sliwerska E, Arnett J, Hortsch M, Hannan F, Burmeister M, Lesperance MM: Increased activity of Diaphanous homolog 3 (DIAPH3)/diaphanous causes hearing defects in humans with auditory neuropathy and in Drosophila. Proc Natl Acad Sci USA 2010;107:13396-13401.
43.
Sharma A, Cardon G: Cortical development and neuroplasticity in auditory neuropathy spectrum disorder. Hear Res 2015;330:221-232.
44.
Starr A, Isaacson B, Michalewski HJ, Zeng FG, Kong YY, Beale P, Paulson GW, Keats BJ, Lesperance MM: A dominantly inherited progressive deafness affecting distal auditory nerve and hair cells. J Assoc Res Otolaryngol 2004;5:411-426.
45.
Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI: Auditory neuropathy. Brain 1996;119:741-753.
46.
Starr A, Rance G: Auditory neuropathy. Handb Clin Neurol 2015;129:495-508.
47.
Starr A, Sininger YS, Pratt H: The varieties of auditory neuropathy. J Basic Clin Physiol Pharmacol 2000;11:215-230.
48.
Stuermer KJ, Beutner D, Foerst A, Hahn M, Lang-Roth R, Walger M: Electrocochleography in children with auditory synaptopathy/neuropathy: diagnostic findings and characteristic parameters. Int J Pediatr Otorhinolaryngol 2015;79:139-145.
49.
Varga R, Avenarius MR, Kelley PM, Keats BJ, Berlin CI, Hood LJ, Morlet TG, Brashears SM, Starr A, Cohn ES, Smith, R J H, Kimberling WJ: OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele. J Med Genet 2006;43:576-581.
50.
Varga R, Kelley PM, Keats BJ, Starr A, Leal SM, Cohn E, Kimberling WJ: Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J Med Genet 2003;40:45-50.
51.
Wagener K, Kühnel V, Kollmeier B: Development and evaluation of a German sentence test. I. Design of the Oldenburg sentence test. Z Audiol 1999;38:4-15.
52.
Wang J, Fan YY, Wang SJ, Liang PF, Wang JL, Qiu JH: Variants of OTOF and PJVK genes in Chinese patients with auditory neuropathy spectrum disorder. PLoS One 2011;6:e24000.
53.
Wang Q, Gu R, Han D, Yang W: Familial auditory neuropathy. Laryngoscope 2003;113:1623-1629.
54.
Wang QJ: AUNX1, a novel locus responsible for X-linked recessive auditory and peripheral neuropathy, maps to Xq23-27.3. J Med Genet 2005;43:e33.
55.
Yan D, Zhu Y, Walsh T, Xie D, Yuan H, Sirmaci A, Fujikawa T, Wong ACY, Loh TL, Du L, Grati M, Vlajkovic SM, Blanton S, Ryan AF, Chen Z-Y, Thorne PR, Kachar B, Tekin M, Zhao H-B, Housley GD, King M-C, Liu XZ: Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise. Proc Natl Acad Sci USA 2013;110:2228-2233.
56.
Zhang Y, Zhou J, Chen Y: Posterior reversible encephalopathy syndrome in a child with steroid-resistant nephrotic syndrome: a case report and review of literature. Int J Clin Exp Pathol 2014;7:4433-4437.
57.
Zong L, Guan J, Ealy M, Zhang Q, Wang D, Wang H, Zhao Y, Shen Z, Campbell CA, Wang F, Yang J, Sun W, Lan L, Ding D, Xie L, Qi Y, Lou X, Huang X, Shi Q, Chang S, Xiong W, Yin Z, Yu N, Zhao H, Wang J, Wang J, Salvi RJ, Petit C, Smith RJH, Wang Q: Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder. J Med Genet 2015;52:523-531.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.